The Hidden
Language of Metabolism.

Insulin is one of the most underutilized signal in medicine. Our sensing technology transforms metabolic health from reactive treatment to proactive mastery.

Obesity • Alzheimer's • Type 2 Diabetes • Hypertension • Obesity • Alzheimer's • Type 2 Diabetes • Hypertension • Obesity • Alzheimer's • Type 2 Diabetes Stroke • Gout • Migraines • Heart Failure • PCOS • Stroke • Gout • Migraines • Heart Failure • PCOS • Cancer • Fatty Liver • Anxiety • Depression • Cancer • Fatty Liver • Anxiety • Depression •

Hyperinsulinemia

The silent driver

THE CHALLENGE

Most Metabolic Disease Begins With a Single, Silent Signal.

Obesity, diabetes, cardiovascular disease, and neurodegeneration share a common root: insulin dysregulation. Yet this critical biomarker remains invisible in routine care—detected only after damage has occurred.

THE SOLUTION

Why Insulin Matters

Beyond glucose control, insulin orchestrates cellular aging, inflammation, cognitive function, and vascular health. Hyperinsulinemia precedes visible disease by years—or decades.

Predictive Window

Elevated insulin appears 10-15 years before glucose abnormalities, offering a critical intervention window.

50%+ Prevalence

More than half of adults have some degree of insulin resistance—most without any symptoms or awareness.

Actionable Data

Real-time insulin monitoring enables precise dietary, lifestyle, and therapeutic interventions tailored to individual response.

CLINICAL APPLICATIONS

Cross-Specialty Utility

Insulin dysregulation underlies disease across cardiology, endocrinology, neurology, and reproductive medicine. Select a condition to explore the evidence.

Colorectal Cancer

Insulin as a mitogenic signal for colonic epithelium.

Endometrial Cancer

Among the most insulin-dependent gynecologic cancers.

Breast Cancer

Insulin as a growth factor for mammary epithelium.

Pancreatic Cancer

The malignancy most linked to hyperinsulinemia.

Depression & Anxiety

The metabolic-mental health bidirectional axis.

Alzheimer's Disease

The 'Type 3 Diabetes’ hypothesis of neurodegeneration.
market opportunity

Insulin Is Moving Upstream in Clinical Care

The role of insulin is expanding beyond diabetes.

Clinical evidence shows it is a critical biomarker in time-sensitive conditions and an early indicator of metabolic risk — long before glucose and HbA1c become abnormal.

40M+

Test / year

Across chronic metabolic conditions where insulin adds early clinical insight.

150M+

PEOPLE

People globally affected by insulin-driven metabolic dysfunction across women’s health, obesity, and early cardiometabolic risk.

10+

year

Earlier metabolic insight vs glucose-based diagnostics.

team

Join us

We’re building Hybolic to solve one of the hardest problems in metabolic health.
This requires exceptional people. If you’re excited about what we’re creating but don’t see a matching role, send us your CV through the Open Application form.

Early team, real ownership

As part of a small founding team, your work will directly shape the product, technology, and company.

Build breakthrough technology

Work at the intersection of science, engineering, and deep-tech innovation.

Move fast, learn faster

We value curiosity, initiative, and people who want to grow while solving hard problems.

Request Access

Join our growing waitlist of people and our team will keep
you updated.

Request Access